This Article Free upon publication Full Text Full Text (PDF) All Versions of this Article: 115/23/2995    most recent CIRCULATIONAHA.106.183216v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jenkins, K. J. Articles by Webb, C. L. Search for Related Content PubMed PubMed Citation Articles by Jenkins, K. J. Articles by Webb, C. L. Related Collections AHA Statements and Guidelines Cardiac development

(Circulation. 2007;115:2995-3014.)
© 2007 American Heart Association, Inc.

AHA Scientific Statements

Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge

A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics

Kathy J. Jenkins, MD, MPH, FAHA; Adolfo Correa, MD, MPH, PhD, FACE; Jeffrey A. Feinstein, MD, MPH; Lorenzo Botto, MD; Amy E. Britt, MS, FAHA; Stephen R. Daniels, MD, PhD, FAHA; Marsha Elixson, RN, MS, FAHA; Carole A. Warnes, MD; Catherine L. Webb, MD, MS, FAHA

Prevention of congenital cardiovascular defects has been hampered by a lack of information about modifiable risk factors for abnormalities in cardiac development. Over the past decade, there have been major breakthroughs in the understanding of inherited causes of congenital heart disease, including the identification of specific genetic abnormalities for some types of malformations. Although relatively less information has been available on noninherited modifiable factors that may have an adverse effect on the fetal heart, there is a growing body of epidemiological literature on this topic. This statement summarizes the currently available literature on potential fetal exposures that might alter risk for cardiovascular defects. Information is summarized for periconceptional multivitamin or folic acid intake, which may reduce the risk of cardiac disease in the fetus, and for additional types of potential exposures that may increase the risk, including maternal illnesses, maternal therapeutic and nontherapeutic drug exposures, environmental exposures, and paternal exposures. Information is highlighted regarding definitive risk factors such as maternal rubella; phenylketonuria; pregestational diabetes; exposure to thalidomide, vitamin A cogeners, or retinoids; and indomethacin tocolysis. Caveats regarding interpretation of possible exposure-outcome relationships from case-control studies are given because this type of study has provided most of the available information. Guidelines for prospective parents that could reduce the likelihood that their child will have a major cardiac malformation are given. Issues related to pregnancy monitoring are discussed. Knowledge gaps and future sources of new information on risk factors are described.

Key Words: AHA Scientific Statements • heart defects, congenital • heart disease • risk factors

This article has been cited by other articles:

				N. Oyen, G. Poulsen, H. A. Boyd, J. Wohlfahrt, P. K.A. Jensen, and M. Melbye Recurrence of Congenital Heart Defects in Families Circulation, July 28, 2009; 120(4): 295 - 301. [Abstract] [Full Text] [PDF]

				M. S. Sklansky, D. P. Berman, J. D. Pruetz, and R.-K. R. Chang Prenatal Screening for Major Congenital Heart Disease: Superiority of Outflow Tracts Over the 4-Chamber View J. Ultrasound Med., July 1, 2009; 28(7): 889 - 899. [Abstract] [Full Text] [PDF]

				R. Ionescu-Ittu, A. J Marelli, A. S Mackie, and L. Pilote Prevalence of severe congenital heart disease after folic acid fortification of grain products: time trend analysis in Quebec, Canada BMJ, May 12, 2009; 338(may12_2): b1673 - b1673. [Abstract] [Full Text] [PDF]

				E. Goldmuntz, S. Woyciechowski, D. Renstrom, P. J. Lupo, and L. E. Mitchell Variants of Folate Metabolism Genes and the Risk of Conotruncal Cardiac Defects Circ Cardiovasc Genet, December 1, 2008; 1(2): 126 - 132. [Abstract] [Full Text] [PDF]

				K. Stankunas, C. Shang, K. Y. Twu, S.-C. Kao, N. A. Jenkins, N. G. Copeland, M. Sanyal, L. Selleri, M. L. Cleary, and C.-P. Chang Pbx/Meis Deficiencies Demonstrate Multigenetic Origins of Congenital Heart Disease Circ. Res., September 26, 2008; 103(7): 702 - 709. [Abstract] [Full Text] [PDF]

				O. J. Benavidez, K. Gauvreau, K. J. Jenkins, and T. Geva Diagnostic Errors in Pediatric Echocardiography: Development of Taxonomy and Identification of Risk Factors Circulation, June 10, 2008; 117(23): 2995 - 3001. [Abstract] [Full Text] [PDF]

				K. J. Jenkins and A. Correa Academy endorses AHA statements on genetic basis, noninherited risk factors for congenital heart defects AAP News, August 1, 2007; 28(8): 39 - 39. [Full Text] [PDF]

				M. E. Pierpont, C. T. Basson, D. W. Benson Jr, B. D. Gelb, T. M. Giglia, E. Goldmuntz, G. McGee, C. A. Sable, D. Srivastava, and C. L. Webb Genetic Basis for Congenital Heart Defects: Current Knowledge: A Scientific Statement From the American Heart Association Congenital Cardiac Defects Committee, Council on Cardiovascular Disease in the Young: Endorsed by the American Academy of Pediatrics Circulation, June 12, 2007; 115(23): 3015 - 3038. [Abstract] [Full Text] [PDF]